Literature DB >> 571718

Molecular and tissue-specific heterogeneity in HPRT deficiency.

M P Uitendaal, C H de Bruyn, T L Oei, P Hösli.   

Abstract

In several patients with different degrees of HPRT deficiencies, residual activities have been determined in both lysed and intact erythrocytes. No close correlation could be found between the degree of HPRT deficiency and the severity of the clinical expression. Unless HPRT activity in both intact and lysed erythrocytes was below detection level, the residual activity in intact red blood cells was higher than in lysates. Tissue-specific heterogeneity was illustrated with a patient suffering from X-linked gout. Lysates from erythrocytes, leukocytes, and cultured fibroblasts showed 1%, 8%, and 100% of normal HPRT activity, respectively. Characterization of the erythrocyte and fibroblast HPRT from this patient showed no kinetic abnormalities. However, there was a decreased heat stability. It is concluded that for a better understanding of the pathophysiology in HPRT deficiency studies on nucleated cells from the different tissues are needed.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 571718     DOI: 10.1007/bf00484539

Source DB:  PubMed          Journal:  Biochem Genet        ISSN: 0006-2928            Impact factor:   1.890


  31 in total

1.  Hypoxanthine phosphoribosyltransferase activity in intact fibroblasts from patients with X-linked hyperuricemia.

Authors:  M J Holland; A M DiLorenzo; J Dancis; M E Balis; T F Yü; R P Cox
Journal:  J Clin Invest       Date:  1976-06       Impact factor: 14.808

2.  A specific enzyme defect in gout associated with overproduction of uric acid.

Authors:  W N Kelley; F M Rosenbloom; J F Henderson; J E Seegmiller
Journal:  Proc Natl Acad Sci U S A       Date:  1967-06       Impact factor: 11.205

3.  Azaguanine-resistance as a manifestation of a new form of metabolic overproduction of uric acid.

Authors:  P J Benke; N Herrick
Journal:  Am J Med       Date:  1972-04       Impact factor: 4.965

4.  Evidence for molecular alteration of erythrocyte hypoxanthine-guanine phosphoribosyltransferase in a gouty family with partial deficiency of the enzyme.

Authors:  O Sperling; P Boer; G Eilam; A de Vries
Journal:  Rev Eur Etud Clin Biol       Date:  1972-01

5.  Kinetic studies of hypoxanthine-guanine phosphoribosyltransferase.

Authors:  J F Henderson; L W Brox; W N Kelley; F M Rosenbloom; J E Seegmiller
Journal:  J Biol Chem       Date:  1968-05-25       Impact factor: 5.157

6.  A new assay method for hypoxanthine-guanine phosphoribosyltransferase.

Authors:  D C Chow; F S Kawahara; T Saunders; L B Sorensen
Journal:  J Lab Clin Med       Date:  1970-11

7.  Incorporation of purine bases by intact red blood cells.

Authors:  C H de Bruyn; T L Oei
Journal:  Adv Exp Med Biol       Date:  1977       Impact factor: 2.622

8.  Disparate enzyme activity in erythocytes and leukocytes. A variant of hypoxanthine phosphoribosyl-transferase deficiency with an unstable enzyme.

Authors:  J Dancis; L C Yip; R P Cox; S Piomelli; M E Balis
Journal:  J Clin Invest       Date:  1973-08       Impact factor: 14.808

9.  Lesch-Nyhan syndrome: altered kinetic properties of mutant enzyme.

Authors:  J A McDonald; W N Kelley
Journal:  Science       Date:  1971-02-19       Impact factor: 47.728

10.  Synthesis of an enzyme determined by an erythrocyte nucleus in a hybrid cell.

Authors:  H Harris; P R Cook
Journal:  J Cell Sci       Date:  1969-07       Impact factor: 5.285

View more
  2 in total

1.  Mechanisms for phenotypic variation in Lesch-Nyhan disease and its variants.

Authors:  Radhika Sampat; Rong Fu; Laura E Larovere; Rosa J Torres; Irene Ceballos-Picot; Michel Fischbach; Raquel de Kremer; David J Schretlen; Juan Garcia Puig; H A Jinnah
Journal:  Hum Genet       Date:  2010-10-28       Impact factor: 4.132

2.  Partial hypoxanthine-guanine phosphoribosyl transferase deficiency with full expression of the Lesch-Nyhan syndrome.

Authors:  G Rijksen; G E Staal; M J van der Vlist; F a Beemer; J Troost; W Gutensohn; J P van Laarhoven; C H de Bruyn
Journal:  Hum Genet       Date:  1981       Impact factor: 4.132

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.